Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

2.

The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.

Roeters van Lennep HW, Liem AH, Dunselman PH, Dallinga-Thie GM, Zwinderman AH, Jukema JW.

Curr Med Res Opin. 2008 Mar;24(3):685-94. doi: 10.1185/030079908X273273. Epub 2008 Jan 25.

PMID:
18226326
3.

Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets.

McCormack T, Harvey P, Gaunt R, Allgar V, Chipperfield R, Robinson P; IN-PRACTICE study.

Int J Clin Pract. 2010 Jul;64(8):1052-61. doi: 10.1111/j.1742-1241.2010.02429.x. Epub 2010 May 12.

PMID:
20487050
4.

Statin plus ezetimibe treatment in clinical practice: the SI-SPECT (Slovenia (SI) Statin Plus Ezetimibe in Cholesterol Treatment) monitoring of clinical practice study.

Fras Z, Mikhailidis DP.

Curr Med Res Opin. 2008 Sep;24(9):2467-76. doi: 10.1185/03007990802303772 . Epub 2008 Jul 24.

PMID:
18655751
5.

Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome.

Simons L, Tonkon M, Masana L, Maccubbin D, Shah A, Lee M, Gumbiner B.

Curr Med Res Opin. 2004 Sep;20(9):1437-45.

PMID:
15383192
7.

Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.

Catapano AL, Davidson MH, Ballantyne CM, Brady WE, Gazzara RA, Tomassini JE, Tershakovec AM.

Curr Med Res Opin. 2006 Oct;22(10):2041-53.

PMID:
17022864
8.

Comparative efficacy of the addition of ezetimibe to statin vs statin titration in patients with hypercholesterolaemia: systematic review and meta-analysis.

Mikhailidis DP, Lawson RW, McCormick AL, Sibbring GC, Tershakovec AM, Davies GM, Tunceli K.

Curr Med Res Opin. 2011 Jun;27(6):1191-210. doi: 10.1185/03007995.2011.571239. Epub 2011 Apr 7. Review.

PMID:
21473671
9.

Lipid-altering efficacy of ezetimibe/simvastatin 10/40 mg compared with doubling the statin dose in patients admitted to the hospital for a recent coronary event: the INFORCE study.

Reckless JP, Henry P, Pomykaj T, Lim ST, Massaad R, Vandormael K, Johnson-Levonas AO, Lis K, Brudi P, Allen C.

Int J Clin Pract. 2008 Apr;62(4):539-54. doi: 10.1111/j.1742-1241.2008.01697.x. Epub 2008 Feb 11.

PMID:
18266852
10.

Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy.

Mikhailidis DP, Sibbring GC, Ballantyne CM, Davies GM, Catapano AL.

Curr Med Res Opin. 2007 Aug;23(8):2009-26.

PMID:
17659159
11.

[Statin-ezetimibe combination in hyperlipidemia treatment].

Vareka T, Vítková D, Zeman M, Vecka M, Zák A.

Cas Lek Cesk. 2012;151(1):17-21. Czech.

PMID:
22442891
12.

Ezetimibe: a novel option for lowering cholesterol.

Davidson MH.

Expert Rev Cardiovasc Ther. 2003 May;1(1):11-21. Review.

PMID:
15030293
13.

Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.

Pearson TA, Ballantyne CM, Veltri E, Shah A, Bird S, Lin J, Rosenberg E, Tershakovec AM.

Am J Cardiol. 2009 Feb 1;103(3):369-74. doi: 10.1016/j.amjcard.2008.09.090. Epub 2008 Oct 30.

PMID:
19166691
14.

Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.

Sampalis JS, Bissonnette S, Habib R, Boukas S; Ezetrol Add-On Investigators.

Ann Pharmacother. 2007 Sep;41(9):1345-51. Epub 2007 Jul 31.

PMID:
17666579
15.

Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia.

Assmann G, Kannenberg F, Ramey DR, Musliner TA, Gutkin SW, Veltri EP.

Curr Med Res Opin. 2008 Jan;24(1):249-59.

PMID:
18053317
16.

Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study).

Ballantyne CM, Weiss R, Moccetti T, Vogt A, Eber B, Sosef F, Duffield E; EXPLORER Study Investigators.

Am J Cardiol. 2007 Mar 1;99(5):673-80. Epub 2007 Jan 4.

PMID:
17317370
17.

Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease.

Teoh H, Mendelsohn AA, Goodman SG, Jaffer S, Chen RY, Tjia S, Theriault L, Langer A, Leiter LA; Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE) Investigators.

Am J Cardiol. 2009 Sep 15;104(6):798-804. doi: 10.1016/j.amjcard.2009.05.019. Epub 2009 Jul 23.

PMID:
19733714
18.

Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.

Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E; Ezetimibe Study Group.

J Womens Health (Larchmt). 2004 Dec;13(10):1101-7.

PMID:
15650343
19.

Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?

Piorkowski M, Fischer S, Stellbaum C, Jaster M, Martus P, Morguet AJ, Schultheiss HP, Rauch U.

J Am Coll Cardiol. 2007 Mar 13;49(10):1035-42. Epub 2007 Feb 23.

20.
Items per page

Supplemental Content

Write to the Help Desk